Multiplex gene regulation by CRISPR-ddCpf1

Cell Discovery

Volumn 3, Issue , 2017, Pages

  Zhang, Xiaochun ^a,b,c   Wang, Jin ^a   Wang, Jingman ^d,e   Cheng, Qiuxiang ^f   Zheng, Xuan ^a   Zhao, Guoping ^a  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b SHANGHAITECH UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d SHENZHEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f Shanghai Personal Biotechnology Limited Company   (China)

Author keywords

Cpf1; CRISPR; CRISPRi; DNase dead Cpf1 (ddCpf1); Multiplex gene regulation

Indexed keywords

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS RNA; DEOXYRIBONUCLEASE; DNASE DEAD CPF1; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CONTROL; GENE REPRESSION; GENE TARGETING; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE; TRANSCRIPTOMICS;

EID: 85022113341     PISSN: None     EISSN: 20565968     Source Type: Journal    
DOI: 10.1038/celldisc.2017.18     Document Type: Article

References (52)

1. Marraffini LA. CRISPR-Cas immunity in prokaryotes. Nature 2015; 526: 55-61.
2. Wang H, La Russa M, Qi LS. CRISPR/Cas9 in genome editing and beyond. Annu Rev Biochem 2016; 85: 227-264.
3. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014; 157: 1262-1278.
4. Wright AV, Nunez JK, Doudna JA. Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering. Cell 2016; 164: 29-44.
5. Mougiakos I, Bosma EF, de Vos WM, van Kranenburg R, van der Oost J. Next generation prokaryotic engineering: the CRISPR-Cas toolkit. Trends Biotechnol 2016; 34: 575-587.
6. Qi LS, Larson MH, Gilbert LA et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013; 152: 1173-1183.
7. Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 2013; 41: 7429-7437.
8. Gilbert LA, Larson MH, Morsut L et al. CRISPR-mediated modular RNA-guided regulation of transcrip-tion in eukaryotes. Cell 2013; 154: 442-451.
9. Konermann S, Brigham MD, Trevino AE et al. Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013; 500: 472-476.
10. Gilbert LA, Horlbeck MA, Adamson B et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 2014; 159: 647-661.
11. Horlbeck MA, Gilbert LA, Villalta JE et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife 2016; 5: e19760.
12. Wang Y, Zhang ZT, Seo SO et al. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9. Biotechnol Bioeng 2016; 113: 2739-2743.
13. Stachler AE, Marchfelder A. Gene repression in haloarchaea using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B system. J Biol Chem 2016; 291: 15226-15242.
14. Didovyk A, Borek B, Hasty J, Tsimring L. Orthogonal modular gene repression in Escherichia coli using engineered CRISPR/Cas9. ACS Synth Biol 2016; 5: 81-88.
15. Luo ML, Mullis AS, Leenay RT, Beisel CL. Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res 2015; 43: 674-681.
16. Black JB, Adler AF, Wang HG et al. Targeted epigenetic remodeling of endogenous loci by CRISPR/Cas9-based transcriptional activators directly converts fibroblasts to neuronal cells. Cell Stem Cell 2016; 19: 406-414.
17. Vora S, Tuttle M, Cheng J, Church G. Next stop for the CRISPR revolution: RNA-guided epigenetic regulators. FEBS J 2016; 283: 3181-3193.
18. Himeda CL, Jones TI, Jones. PL. CRISPR/dCas9-medi-ated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy. Mol Ther 2016; 24: 527-535.
19. Vojta A, Dobrinic P, Tadic V et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res 2016; 44: 5615-5628.
20. Kabadi AM, Ousterout DG, Hilton IB, Gersbach CA. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res 2014; 42: e147.
21. Ungerer J, Pakrasi HB. Cpf1 is a versatile tool for crispr genome editing across diverse species of cyanobacteria. Sci Rep 2016; 6: 39681.
22. Endo A, Masafumi M, Kaya H, Toki S. Efficient targeted mutagenesis of rice and tobacco genomes using Cpf1 from Francisella novicida. Sci Rep 2016; 6: 38169.
23. Xu R, Qin R, Li H et al. Generation of targeted mutant rice using a CRISPR-Cpf1 system. Plant Biotechnol J 2017; 15: 713-717.
24. Toth E, Weinhardt N, Bencsura P et al. Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells. Biol Direct 2016; 11: 46.
25. Kim Y, Cheong SA, Lee JG et al. Generation of knockout mice by Cpf1-mediated gene targeting. Nat Biotechnol 2016; 34: 808-810.
26. Hur JK, Kim K, Been KW et al. Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat Biotechnol 2016; 34: 807-808.
27. Fagerlund RD, Staals RH, Fineran PC. The Cpf1 CRISPR-Cas protein expands genome-editing tools. Genome Biol 2015; 16: 251.
28. Zetsche B, Gootenberg JS, Abudayyeh OO et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 2015; 163: 759-771.
29. Fonfara I, Richter H, Bratovic M, Le Rhun A, Charpentier E. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 2016; 532: 517-521.
30. Zetsche B, Heidenreich M, Mohanraju P et al. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol 2016; 35: 178.
31. Wang M, Mao Y, Lu Y, Tao X, Zhu JK. Multiplex gene editing in rice using the CRISPR-Cpf1 system. Mol Plant (e-pub ahead of print 16 March 2017; doi:10.1016/j. molp.2017.03.001).
32. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier. E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337: 816-821.
33. Dong D, Ren K, Qiu X et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 2016; 532: 522-526.
34. Yamano T, Nishimasu H, Zetsche B et al. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 2016; 165: 949-962.
35. Leenay RT, Maksimchuk KR, Slotkowski RA et al. Identifying and visualizing functional PAM diversity across CRISPR-Cas Systems. Mol Cell 2016; 62: 137-147.
36. Stock AM, Robinson VL, Goudreau PN. Two-component signal transduction. Annu Rev Biochem 2000; 69: 183-215.
37. Ortet P, Whitworth DE, Santaella C, Achouak W, Barakat M. P2CS: updates of the prokaryotic two-component systems database. Nucleic Acids Res 2015; 43: D536-D541.
38. Zhou L, Lei XH, Bochner BR, Wanner BL. Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J Bacteriol 2003; 185: 4956-4972.
39. Mohr SE, Smith JA, Shamu CE, Neumuller RA, Perrimon. N. RNAi screening comes of age: improved techniques and complementary approaches. Nat Rev Mol Cell Biol 2014; 15: 591-600.
40. Jackson AL, Bartz SR, Schelter J et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635-637.
41. Kleinstiver BP, Tsai SQ, Prew MS et al. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol 2016; 34: 869-874.
42. Kim D, Kim J, Hur JK, Been KW, Yoon SH, Kim JS. Genome-wide analysis reveals specificities of Cpf1 endo-nucleases in human cells. Nat Biotechnol 2016; 34: 863-868.
43. Tang X, Lowder LG, Zhang T et al. A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants. Nat Plants 2017; 3: 17018.
44. Perez-Pinera P, Kocak DD, Vockley CM et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 2013; 10: 973-976.
45. Zalatan JG, Lee ME, Almeida R et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 2015; 160: 339-350.
46. Zheng X, Li SY, Zhao GP, Wang J. An efficient system for deletion of large DNA fragments in Escherichia coli via introduction of both Cas9 and the non-homologous end joining system from Mycobacterium smegmatis. Biochem Biophys Res Commun 2017; 485: 768-774.
47. Li SY, Zhao GP, Wang J. C-Brick: a new standard for assembly of biological parts using Cpf1. ACS Synth Biol 2016; 5: 1383-1388.
48. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8: 2281-2308.
49. Shao ZH, Ren SX, Liu XQ et al. A preliminary study of the mechanism of nitrate-stimulated remarkable increase of rifamycin production in Amycolatopsis mediterranei U32 by RNA-seq. Microb Cell Fact 2015; 14: 75.
50. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105-1111.
51. Trapnell C, Williams BA, Pertea G et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511-515.
52. Dudoit S, Gilbert HN, van der Laan MJ. Resampling-based empirical Bayes multiple testing procedures for controlling generalized tail probability and expected value error rates: focus on the false discovery rate and simulation study. Biom J 2008; 50: 716-744.